無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

勃起不全 (ED):主要29ヶ国の市場予測

Epiomic Epidemiology Series: Erectile Dysfunction Forecast in 29 Major Markets 2017-2027

発行 Black Swan Analysis 商品コード 479876
出版日 ページ情報 英文 62 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.44円で換算しております。
Back to Top
勃起不全 (ED):主要29ヶ国の市場予測 Epiomic Epidemiology Series: Erectile Dysfunction Forecast in 29 Major Markets 2017-2027
出版日: 2017年03月01日 ページ情報: 英文 62 Pages
概要

当レポートでは、世界の主要29ヶ国における勃起不全 (ED) の発症状況について分析し、疾患の概要や現時点での有病者数、サブタイプ別および性別・年代別 (5歳区切り) の詳細状況、地域別・民族別傾向、リスク要因、疾患の診断と予後、主な症状や合併症 (慢性心疾患、高血圧、糖尿病、前立腺肥大症 (BPH)、貧血、うつ病、性欲減退など)、将来的な動向見通し (今後10年間分) といった情報を取りまとめてお届けいたします。

目次

  • 図表一覧
  • イントロダクション
  • 疾患の原因
  • リスク要因と予防法
  • 疾患の診断方法
  • 地域別/民族別の差異
  • 疾患の予後と臨床経過
  • 疾患関連の主な共存症/特徴
  • 患者数の計測方法
  • 勃起不全 (ED) の最大有病者数
  • 勃起不全の特徴
    • ED患者の共存症
  • 文中の略語一覧
  • Black Swan Analysisのその他の刊行物
  • Black Swan Analysisのオンライン・患者ベースのデータベース
  • 患者ベースのサービス
  • オンライン価格データ/プラットフォーム
  • 参考文献
  • 付録

図表一覧

分析対象国

  • アルゼンチン
  • オーストラリア
  • ブラジル
  • カナダ
  • 中国
  • クロアチア
  • エジプト
  • フランス
  • ドイツ
  • ギリシャ
  • インド
  • イタリア
  • 日本
  • メキシコ
  • オランダ
  • ノルウェー
  • ポーランド
  • ポルトガル
  • ルーマニア
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • 韓国
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • 英国
  • 米国
目次
Product Code: EDYS0010317

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Erectile Dysfunction in 29 Major Markets

Erectile dysfunction, also known as ED and impotence, is defined as the frequent inability to achieve or maintain an erection sufficient for sexual activity to take place.

This report provides the current prevalent population for Erectile Dysfunction across 29 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Netherlands, Portugal, Switzerland, Croatia, Poland, Romania, Russia, Norway, Sweden, Greece, Turkey, Saudi Arabia, Egypt, China, Japan, South Korea, India, Australia, South Africa, Brazil, Mexico, Argentina) split 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Erectile Dysfunction have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Erectile Dysfunction disease include:

  • Chronic heart disease
  • Hypertension
  • Diabetes
  • BPH
  • Anaemia
  • Depression
  • Loss of libido

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Erectile Dysfunction market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Erectile Dysfunction and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Erectile Dysfunction prevalent population.
  • Identify sub-populations within Erectile Dysfunction which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Erectile Dysfunction patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Erectile Dysfunction
  • Features of Erectile Dysfunction patients
    • Comorbid conditions of ED patients
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • IIEF-5 questionnaire
  • Prevalence of Erectile Dysfunction, malesl (000s)
  • Severity of ED, males (000s)
  • Smoking status of ED patients, males (000s)
  • Diagnosed with enlarged prostate, males (000s)
  • ED patients with diabetes, males (000s)
  • ED patients with depression, males (000s)
  • ED patients with hypertension, males (000s)
  • Cardiovascular disease, males (000s)
  • ED patients that are overweight (BMI ≥ 25), males (000s)
  • ED patients that are seeking treatment, males (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Canada Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • France Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Germany Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Italy Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Spain Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • UK Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Netherlands Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Portugal Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Switzerland Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Croatia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Poland Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Romania Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Russia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Norway Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Sweden Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Greece Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Turkey Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Saudi Arabia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Egypt Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • China Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Japan Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • South Korea Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • India Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Australia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • South Africa Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Mexico Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
  • Argentina Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
Back to Top